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RESUMEN
La ingesta de aceite de oliva en relación a las enfer-
medades cardiovasculares.
La aterosclerosis es el componente principal en la patogénesis
de la enfermedad arterial coronaria (CAD). Diversos estudios epide-
miológicos, clínicos y metabólicos indican la existencia de una aso-
ciación entre la ingesta de aceite de oliva (virgen extra) y una menor
manifestación de CAD. El aceite de oliva es uno de los componentes
esenciales de la dieta Mediterránea, es rico en ácido oleico (repre-
senta el 29% de la ingesta calórica diaria) y en antioxidantes (vitami-
na E y polifenoles). Tiene efectos beneficiosos al reducir el riesgo
cardiovascular relacionado con la concentración plasmática de LDL,
la relación LDL:HDL, y la oxidación de las LDL. Además, el aceite de
oliva contribuye a la regulación de los sistemas de coagulación y fi-
brinolisis (FVII, PAI-1, XIIc y XIIa). Estas observaciones reafirman la
importancia de las grasas de la dieta para las funciones vitales en el
organismo y la prevención de CAD, donde el aceite de oliva ha de
considerarse como un elemento nutricional determinante.
PALABRAS-CLAVE: Aceite de oliva; Ácidos grasos monoin-
saturados; Enfermedad cardiovascular; Lipoproteínas; Oxida-
ción de LDL; Hemostasia; Dieta Mediterránea.
SUMMARY
Olive oil intake in relation to cardiovascular diseases.
Atherosc leros is  is  the pr inc ipa l  contr ibutor  to  the
pathogenesis of coronary artery disease (CAD). Epidemiological,
cl inical and metabolic studies have reported protective
associations between (extra virgin) olive oil consumption and
CAD. As a key component of the Mediterranean diet, olive oil is a
rich source of oleic acid, making up about 29% of the daily dietary
caloric intake, and antioxidants (vitamin E and phenolic
compounds). Olive oil has beneficial effects by reducing LDL
plasma concentration, the LDL cholesterol:HDL cholesterol ratio,
and protecting LDL against oxidation. The progress of
atherosclerosis and the risk of thrombo-embolic episodes could
also be decreased through the reduction in plasma clotting factors
levels, including FVIIc, PAI-1, XIIc and XIIa. The findings reaffirm
low-moderate fat policies for optimum health, within which olive oil
appears to be an important component of the diet.
KEY-WORDS: Olive oil; Monounsaturated fatty acids; Car-
diovascular disease; Lipoproteins; LDL oxidation; Haemosta-
sis; Mediterranean diet.
1. INTRODUCTION
Doctors such as Galen, Hippocrates and
Dioscorides (Viola and Audisio, 1987) acknowledged
the therapeutic effects of olive oil since antiquity.
Olive oil is extracted from the drupes of Olea
Europaea, which is a tree widely grown in areas of
southern Europe, hence its name, and nowadays,
approximately 98% of the existing olive trees are
being cultivated in the wider Mediterranean basin. 
Olive oil intake differs among the Mediterranean
countries. In the island of Crete, 29% of the caloric
intake from the diet was derived from the
consumption of olive oil (Keys, 1980) and this high
consumption is probably the most important
difference between the Cretan Mediterranean diet
and the diets of the other Mediterranean countries
(Table 1). It is noteworthy that in the Italian and
Spanish traditional diets the daily dietary intake of
olive oil is approximately 15-20 g but in the Cretan
diet is much higher and it reaches 70 g. 
One of the beneficial properties of olive oil is the
reduction of the risk of coronary artery disease
(CAD) through the decrease in plasma cholesterol
and the possible increase of HDL cholesterol levels,
the decrease of LDL susceptibility to oxidation and
the decrease in thrombogenic factors such as factor
VII. The purpose of this article is to review the
epidemiological, clinical and metabolic studies,
which investigated the effects of olive oil and its
constituents on risk factors for developing CAD.
2. EPIDEMIOLOGICAL STUDIES AND CLINICAL
   TRIALS
The interest of olive oil as a cardioprotective food
arose from the results of the Seven Countries Study
(Keys, 1970). This study started in 1960’s and it
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compared the incidence of CAD and the life styles of
populations from 7 countries, namely USA, the
Netherlands, Finland, Japan, Yugoslavia, Italy and
Greece. This study showed for the first time, that the
Greek population from Crete had very low morbidity
and mortality rates from CAD compared to the
populations from the other countries. Additionally,
Cretans were found to have lower plasma cholesterol
levels than the Americans and this difference was
speculated that it might have contributed to the
observed differences in the prevalence of CAD in
these two countries (Christakis et al., 1965).
Differences between the American and the Cretan
cohorts were also observed in the adipose tissue
fatty acid composition. In particular, adipose tissue of
the Cretans had a higher concentration in
monounsaturated fatty acids (MUFA) than the
adipose tissue of the American cohort. This
observation was an indication that the traditional
Cretan diet was high in MUFA, which were mainly
coming from olive oil consumption. 
In the 7 Countries Study, it was also observed
that the Cretan cohort had relatively higher plasma
cholesterol levels than the Italian and Yugoslavian,
but the mortality rates from CAD remained lower
even 25 years after the beginning of the study
(Kromhout et al., 1995) and even for the same
plasma cholesterol levels, the risk for developing
CAD was three times lower in the Mediterranean
populations in comparison to USA and the Northern
European populations (Verschuren et al., 1995). The
last two observations could indicate that factors such
as diet and its components could influence the risk
for developing CAD irrespective plasma cholesterol
levels. However, plasma cholesterol levels were not
correlated with the dietary MUFA intake, and
subsequently olive oil consumption.
In a major secondary prevention trial, the Lyon
Diet Heart Study (De Longeril et al., 1994), it was
observed that deaths of patients with acute
myocardial infarction (AMI) were dramatically
decreased when patients were on a Cretan
Mediterranean diet enriched with a-linolenic acid,
Table 1
Nutrient composition of traditional Cretan Mediterranean diet and other Western type diets
[average daily nutrient intake as percentage (%) of total dietary caloric intake]
Nutrient Cretan
diet
British
diet
Dutch
diet
American
diet
EU
Recommend
ations*
Step 1 AHA
diet**
TLC***
Protein
Fat
Saturated
   Monounsaturated
Polyunsaturated
Carbohydrates
Alcohol
Cholesterol
Dietary fiber
12
43
10
23
3
46
180 mg
13
41
17
14
7
43
10
14
36
15
12
6
49
2
310 mg
30 g
15
38
18
10
10
47
500 mg
20-35
7-10
10-15
< 7-8
> 55-75
24-36 g
< 300 mg
> 25 g
15
30
10
10
10
55
250 mg
~15
25-35
<7
up to 20
up to 10
50-60
<200 mg
20-30 g
*  Eurodiet project (Working Party 1: Final Report, 2001).
**  Diet recommended by the American Heart Association (AHA), Adult Treatment Panel (ATP) II for the treatment of increased plasma lipid
levels, such as cholesterol [Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detec-
tion, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). (2003).JAMA,  269, 3015-3023].
*** Diet recommended by the American Heart Association (AHA), Adult Treatment Panel (ATP) III for the treatment of increased plasma lipid
levels, such as cholesterol (Expert Panel, 2001).
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compared to controls who followed a diet
recommended by American Heart Association
(Renaud et al., 1995; De Longeril et al., 1996; 1998;
1999). More specifically, 605 French volunteers, who
survived of a first MI, were randomized into either a
control or a Cretan Mediterranean diet group. After
27 months of follow-up, 16 cardiac deaths were
observed in the Control and only three in the Cretan
Mediterranean diet group and the risk of new major
cardiac events was reduced by 73% in the
Mediterranean diet group. Moreover, in the later
group, dietary intake of oleic (18:1n-9) and
a-linolenic (18:3n-3) acids as well as dietary fiber,
vitamins E and C were increased, whereas, dietary
saturated fatty acid (SFA) intake was decreased (De
Longeril et al., 1998). Therefore, the beneficial effect
of the Cretan Mediterranean diet could be attributed
partly to olive oil intake.
In another case-control study in Spain (171
patients with first acute AMI and 171
hospital-matched controls), the exposure to the
upper quintile of energy-adjusted olive oil (median
intake: 54 g/day) was associated with a 82% relative
reduction in the risk of a first AMI after adjustment for
dietary and non-dietary cofounders
(Fernandez-Jarne et al., 2002). The same
researchers quantified the risk reduction of incident
MI provided by a Mediterranean dietary pattern, by
creating a score (Martinez-Gonzalez et al., 2002).
Six food items were considered protective, namely
olive oil, fiber, fruits, vegetables, fish and alcohol and
2 non-protective namely meat/meat products and
items with high glycemic load (white bread, pasta,
rice). It was observed that a high score, which means
an adherence to the Mediterranean diet, was
associated with low odds ratio of MI.
However, in a large prospective study, involving
22,043 adults in Greece, even though a higher
adherence to Mediterranean diet was associated
with a reduction in total mortality and death from
coronary heart disease, associations between
individual food groups, including olive oil, and total
mortality were not statistically significant
(Trichopoulou et al., 2003). It is though noteworthy
that in analyses adjusted for age, sex, years of
education, smoking status, body mass index,
waist-to-hip ratio, energy expenditure score and total
energy intake, the only individual measures that were
predictive of total mortality were the intake of fruits and
nuts and the ratio of monounsaturated to saturated
lipids. In addition, the inverse association between
the Mediterranean diet score and total mortality was
evident irrespective of sex, smoking status, level of
education, body mass index, waist-to-hip ratio and
level of physical activity. The presence of weak
associations between individual components of the
Mediterranean diet and total mortality could be due
to the fact that there may be interactions between
these components that may be difficult to detect, and
that the effects of single nutrients may be too small
but the cumulative effects substantial (Trichopoulou
et al., 2003; Hu, 2003).
3. METABOLIC STUDIES
3.1. Plasma lipid levels
Numerous studies suggest that the beneficial
effects of olive oil on plasma lipid levels are partly
due to its MUFA content and the main MUFA of olive
oil, oleic acid, is now widely known to exert
hypocholesterolemic properties, compared to SFA.
More specifically, in a study which compared the
effects of SFA, MUFA and polyunsaturated fatty
acids (PUFA) on plasma lipid levels, MUFA
decreased LDL cholesterol levels, to the same extent
as PUFA (Mattson and Grundy, 1985) but they also
decreased HDL cholesterol levels less often than
PUFA. More recently, when two diets different in fatty
acid composition were given to volunteers with family
history of CAD, the MUFA rich diet decreased
plasma cholesterol and LDL cholesterol levels, and
consequently improved the lipid profile, compared to
the diet rich in SFA (Williams et al., 1999). In the
same study, it was also observed that HDL
cholesterol levels were not altered, and moreover,
the LDL cholesterol:HDL cholesterol ratio was
decreased.
One of the populations that were investigated in
the 7 Countries Study was the Dutch population.
When the effects of a high MUFA diet (15% of the
daily dietary caloric intake) on plasma lipid levels
were compared with the effects of the average diet of
the Dutch volunteers (11% of the daily dietary caloric
intake in the form MUFA), an 18% reduction in
plasma LDL cholesterol levels was observed, even
with this small increase in dietary MUFA intake
(Mensink and Katan, 1989). This reduction in plasma
LDL cholesterol levels was even greater than the
13% reduction, which was observed following a diet
rich in PUFA. The investigators concluded that a diet
rich in MUFA could be at least as beneficial as a diet
rich in PUFA in lowering plasma cholesterol levels. In
contrast, a small decrease in plasma HDL
cholesterol levels was observed in men, at the end of
both dietary periods, but not in women. However, the
high MUFA diet resulted in a better plasma lipemic
improvement since the LDL:HDL ratio was lower
than after the PUFA rich diet.
Apart from studies in European populations,
similar interventions have been carried out in
American cohorts. In one of the recent studies in
American volunteers, the average American diet
(38% fat, 18% SFA, 10% MUFA, 10% PUFA, 47%
carbohydrate, 15% protein, 500 mg cholesterol) was
compared with the diet that American Heart
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Association recommended at that time (Step I diet)
for lowering plasma lipid levels (31.5% fat, 9.9% SFA,
11.3% MUFA, 10.3% PUFA, 51.7% carbohydrate,
16.6% protein, 241 mg cholesterol), and with another
diet enriched with MUFA, which also increased the
total fat intake (37.3% fat, 9.2% SFA, 17.8% MUFA,
10.3% PUFA, 46.2 % carbohydrate, 16.2% protein,
215 mg cholesterol) (Ginsberg et al., 1990). It was
observed that the MUFA rich diet was as beneficial in
lowering plasma lipids (total and LDL cholesterol), as
the American Heart Association diet. A closer look,
however, in the results, would indicate that there was
a trend towards a bigger reduction in total cholesterol
and LDL cholesterol levels at the end of the MUFA
diet than at the end of the Step I diet, but the
statistical power was not enough to permit direct
comparison between the two diets. Both diets did not
alter significantly HDL cholesterol and triglycerides
levels compared to the control average American
diet. 
In mildly hypercholesterolemic subjects, a 6
weeks MUFA diet decreased total cholesterol and
apolipoprotein B levels and the addition of n-3 atty
acids did not decrease serum lipids any further
(Puiggros et al., 2002). However, the n-3 diet
increased lipoperoxide levels in isolated native LDL,
which would indicate higher LDL oxidation. On the
other hand, Pedersen et al. (2000) reported
beneficial effects of rapeseed oil compared to olive
oil diets in plasma lipids although at the end of the
olive oil diet period higher concentrations of HDL2
and large and buoyant LDL were observed. 
In the postprandial state, it was observed that
Northern Europeans (British and Irish) clear fat from
blood circulation at a slower rate than Cretans after
fat containing meals (Zampelas et al., 1998). The
faster rate of absorption and subsequent metabolism
of fat, may partly explain the decreased risk for
developing CAD in Cretans. In addition, in a British
cohort, even a small increase in MUFA in the diet
(from 12% to 18% of dietary daily caloric intake)
resulted to a 14% decrease in plasma LDL
cholesterol levels and a maintenance of plasma HDL
cholesterol levels compared to their usual habitual
diet which was rich in SFA (Williams et al., 1999).
This dietary intervention which lasted for 8 weeks
resulted also in an improvement of the postprandial
plasma triglycerides response, following a meal with
specific fatty acid composition (Roche et al., 1998).
Studies also showed that fatty acid composition of
acute test meals does not seem to affect
postprandial plasma lipid levels responses (Jackson
et al., 1999; Nielsen et al., 2000). In another study,
extra virgin olive oil intake attenuated postprandial
triglyceride concentration and increased triglyceride
disappearance in triglyceride-rich lipoproteins
compared to high oleic sunflower oil, suggesting that
MUFA content may not be the only predictor of
postprandial metabolism of triglycerides (Abia et al.,
2001). Mekki et al. (2002) reported lower
postprandial lipemia and chylomicron accumulation
in the circulation of young healthy men following a
test meal containing butter than meals containing
either olive oil or sunflower oils. However 20% of fatty
acids from butter are of short and medium chain and
these fatty acids are not incorporated into
chylomicrons and therefore interpretation of these
results should be made with caution. 
Olive oil has also beneficial properties on lipemic
profile, compared to dietary carbohydrates. In
particular, when a diet rich in olive oil (24-28% of
daily dietary caloric intake) was compared with a
high carbohydrate diet (60% as energy), the high
carbohydrate diet resulted to a decrease in plasma
HDL cholesterol and an increase in triglyceride levels
(Grundy, 1986; Mensink and Katan, 1987). Moreover,
a diet rich in carbohydrates may cause adverse
effects in the treatment of metabolic syndrome
insulin resistance and subsequent type 2 diabetes. In
particular, a diet high in carbohydrates may worsen
the lipemic profile and deteriorate the already
existing hyperglycemic response. Thus, a diet high in
MUFA, such as commonly consumed in the
Mediterranean region, appears to be the preferable
diet for patients with the metabolic syndrome
(Grundy, 1999). 
The beneficial effects of MUFA in plasma lipid
l vels led to a consensus and the new guidelines of
the National Cholesterol Education Program for the
treatment of hypercholesterolemia in adults suggest
a change in lifestyle factors (Therapeutic Lifestyle
Changes, TLC). According to these new guidelines,
dietary fat intake could be as high as 35% of the total
energy intake and MUFA should provide up to 20%
of energy (Expert Panel, 2001; 2002). These
guidelines also suggest that for the treatment of the
metabolic syndrome, diets even higher in fat content
could be followed providing that the additional fat is in
the form of MUFA. These guidelines are more liberal
in the dietary fat intake recommendations than the
Adult Treatment Panel (ATP) II guidelines (Step I and
Step II diets), and it is also obvious that special
emphasis is given in the dietary MUFA intake. 
Oleic acid is probably oxidized in a different
degree than saturated fats. In a recent study, stable
isotope tracer methodologies, in combination with
indirect calorimetry, were used to determine the
oxidation of dietary fats in subjects fed a MUFA diet
and a SFA diet (Jones et al., 1999). The results from
this study suggested that fatty acid composition of
background diet may influence the relative
proportion of fat oxidation, that is attributed to
exogenous (i.e. dietary) and endogenous fat
oxidation. It was suggested that even a relatively
small increase in SFA content of a diet, compared to
MUFA, could decrease exogenous fat oxidation.
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3.2. LDL oxidation
Olive oil has beneficial effects against LDL
oxidation. It is now well known that PUFA increase
LDL oxidation, compared to MUFA (Reaven et al.,
1991; 1993). In the Jerusalem Study, a PUFA rich
diet lead to increased LDL oxidation compared to a
MUFA rich diet (Berry et al., 1991). In addition, LDL
was less susceptible to lipid peroxidation in
volunteers with mildly elevated plasma cholesterol
levels after following a diet rich in MUFA than in
PUFA (Reaven et al., 1993). In a more recent study,
it was also demonstrated that low fat, such as the
Step II diet of the American Heart Association, and
high MUFA diets have similar effects on LDL
oxidative resistance by lowering oxidation rates and
this was associated with a lower PUFA content in
LDL (Hargrove t al., 2001).
Another factor which influences LDL oxidation is
the presence of antioxidants, such as vitamin E and
polyphenols. Extra virgin olive oil composition is
unique in this respect because it is rich in both
MUFA, which have increased resistance to oxidation,
and vitamin E and phenolic compounds, such as
flavonoids, which decrease even further the
susceptibility of LDL to oxidation. Extra virgin olive oil
consists of 55-85% oleic acid, tocopherols (5-10
mg/100 g, 95% a-tocopherol), carotenoids (1-2
mg/100 g), phenolic compounds such as oleuropein
(20-500 mg/L), and phytosterols (98-185 mg/100 g)
(Stark and Madar, 2002). It has already been
observed that an increase in vitamin E levels in blood
circulation decreases the risk for developing CAD
(Stampfer et al., 1993). The daily vitamin E and other
antioxidant’s requirements seem now to be
dependent on the degree of unsaturation of dietary
fatty acids and their concentration in blood
circulation. LDL, formed following a diet rich in
MUFA, tend to be resistant to lipid peroxidation
(Steinberg and Witztum, 1990; Mata et al., 1997).
Even though the extent by which the balance
between dietary antioxidants and the degree of fatty
acid unsaturation influences the risk for developing
CAD is still unknown, the high concentration of
vitamin E and the predominance of MUFA in olive
oil seem to contribute to the low prevalence of
CAD. However, the issue of vitamin E as a
protective vitamin against CAD remains
unresolved. Although epidemiological (Gey et al.,
1991; Stampfer et al., 1993; Rimm et al., 1993) and
metabolic studies (Esterbauer et al., 1991; Green
et al., 1998) showed beneficial effects of vitamin E
on CAD mortality rates and risk factors of CAD
respectively, in the secondary prevention, vitamin
E supplementation failed to show any benefit
(Stephens et al., 1996; Mitchinson et al., 1999). It
could be argued that the effect is dose- and
time-dependent and in order to see any benefit one
should ingest small amounts for long time periods
and not large for short time. Another explanation
could be that there is a synergistic effect of
a-tocopherol with other antioxidants, such as
polyphenols, in the diet. However, research is still
necessary in this area.
Squalene is another minor constituent of olive oil
(500-700 mg/kg). Squalene has been reported to inhibit
the activity of HMG-CoA reductase, the key enzyme for
cholesterol synthesis (Visioli and Galli, 2002).
In general, the beneficial effects of phenols which
are present in extra virgin olive oil are considered to
be partly through the inhibition of LDL oxidation
(Visioli and Galli, 1998). The major phenolic
compounds in extra virgin olive oil are oleuropein,
hydroxytyrosol and tyrosol, and it is now well
established that flavonoids and phenolic compounds
are absorbed from the diet. There is evidence that
their bioavailability in extra virgin olive oil, especially
hydroxytyrosol bioavailability, is high since they are
easily conveyed to the oil by the pressing of the
drupe (Visioli and Galli, 2002; Tuck and Hayball,
2002). In vitro studies showed that olive oil phenolics
could increase lag time of conjugated diene
formation after copper-mediated LDL oxidation and
inhibit thiobarbituric acid reactive substances after
AAPH-initiated LDL oxidation (Fito et al., 2000;
Leenen et al., 2002). This is in accordance with the
results of a trial which showed a significant
correlation of the lag phase of conjugated diene
formation and the increase in plasma phenolic
content at the end of a 4 weeks extra virgin olive oil
supplementation period (20 g/day) (Masella et l.,
2001). The differences observed were not correlated
with LDL fatty acid composition or vitamin E content
which suggests a protective effect of phenolic
compounds of extra virgin olive oil against LDL
oxidation. In contrast, no effect of olive oil phenols
was observed on markers of oxidation in smokers
(Moschandreas et al., 2002) which could indicate
that smokers need higher intakes of antioxidants.
Moreover, in another study, no difference in the
resistance of LDL and HDL to oxidation was
observed between phenol-rich and phenol-poor
extra virgin olive oil diets in healthy volunteers
(Vissers et al., 2001). However, in this study the
intake of olive oil was unrealistically high and the
supplementation period was relatively short (69 g for
3 weeks) and therefore intervention studies in
physiological conditions would give further
information regarding the effect of olive oil
polyphenols on LDL susceptibility to oxidation. 
3.3. Anti-thrombotic properties
Apart from its anti-atherogenic properties, olive
oil has also anti-thrombotic properties. Although
arly findings showed an increase in factor VIIc
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following a high oleic acid meal (Oakley et al., 1998;
Sanders et al., 1999), other studies demonstrated a
beneficial effect of olive oil rich diets on haemostasis.
Roche et al. (1998) found that a diet rich in MUFA
reduces plasma factor VII levels, following the
consumption of a test meal, and Larsen et al.(1999)
observed that a 3-weeks olive oil diet lowers
non-fasting mean and peak concentrations of FVIIa
than a sunflower oil diet (Kelly et al., 2001). In
addition, a 16-weeks MUFA diet resulted in a less
postprandial FVII activation and beneficial changes
in whole-blood platelet aggregation in healthy young
adults as compared to a SFA diet.
Another study compared the effects of a diet rich
in MUFA on plasminogen activating inhibitor-1
(PAI-1) levels with the effects of a low fat diet on the
same parameter (Lopez-Segura et al., 1996). PAI-1
inactivates the function of endogenous plasminogen
activator in the tissues, which leads to thrombus
breakdown and as a consequence, PAI-1 increases the
risk for developing thrombosis. This study indicate
that a diet rich in PUFA decreased plasma PAI-1
levels and as a result the risk for thrombogenesis.
Another, more recent study, indicated that oleic acid
decreases plasma factor VII and PAI-1 levels,
compared to palmitic acid (Temme et al., 1999). In
contrast, work by Tholstrup et al. (1999) indicated no
benefit from a MUFA diet on t-PA activity and PAI-1
antigen levels, which means that more research is
necessary in this area. However, after comparing
the response to a low-fat meal, with a high-fat
meal, the later increased plasma factor VII levels,
regardless of the fatty acid composition of the meal
(Oakley et al., 1998) and therefore, it seems that the
impact of dietary fat composition on fasting FVII
concentrations is not as pronounced as the impact of
total fat intake (Marckmann et al., 1998).
In another study, a 4-weeks olive oil diet
decreased coagulation factors VIIc, XIIc, XIIa, and
Xc compared to a wash-in SFA diet in healthy
individuals (Junker et al., 2001). In the same study
the rapeseed oil diet did not have any effect and the
sunflower oil diet decreased FXIIc, FXIIa and FIXc.
t-PA and PAI-1 were not influenced in the olive oil and
sunflower oil diets and therefore fibrinolysis was not
affected.
3.4. Markers of inflammation and infection
It is now well known that the immune system
plays an important role in the inflammatory events
leading to atherosclerosis. Animal studies have
shown that olive oil suppresses natural killer cell
activity (Yaqoob et al., 1994a), mitogen-stimulated
proliferation (Yaqoob et al., 1994b; 1995) and
expression of receptors for interleukin 2 and
transferrin (Yaqoob et al., 1994b) in leucocytes.
However, in a human trial it was also demonstrated
that an 8-weeks olive oil diet decreased the
expression of intercellular adhesion molecule 1 by
peripheral blood mononuclear cells but did not affect
natural killer cell activity or proliferation of
mitogen-stimulated leucocytes (Yaqoob et al., 1998).
4. CONCLUSION
Olive oil and its constituents have beneficial
effects on plasma lipid metabolism. The effects
include decrease of LDL cholesterol and probable
increase in HDL cholesterol levels. Apart from its
effects on plasma lipid levels, olive oil, decreases
LDL oxidation, rendering these lipoprotein particles
less atherogenic (Table 2). The progress of
atherosclerosis and the risk of thrombo-embolic
Table 2
Effects of olive oil on biochemical parameters in blood circulation, which influence atherogenesis
and thrombogenesis
Parameter Influence of olive oil
Effect on atherogenesis
     LDL-C
     HDL-C
     oxidized LDL
Effect on thrombogenesis
     FVII
     PAI-1
-
+
-
-
-
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episodes could also be decreased through the
reduction in several plasma clotting factors levels
such as FVIIc, XIIc and XIIa. Finally, there is
evidence that olive oil could affect parameters which
play a role in the inflammation response.
The increase in olive oil intake to a level, similar to
the one observed in the Cretan Mediterranean diet
and its adoption as a wider European Union policy
and recommendation for its citizens, would probably
have a major impact in the annual production of olive
oil which would have to reach 14,000 tons. This
target is probably beyond the present capacity and
would have land-use implications since olive oil
production would have to displace pastures and the
production of other crops (Gibney and Roche, 2001).
However all these issues have to be considered
when a public health nutrition policy is to be applied
in such a wide range of populations taking into
account their cultural and economic backgrounds.
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